Yahoo
XETRA - Delayed Quote EUR

Sartorius Aktiengesellschaft (SRT.DE)

228.00 -1.00 (-0.44%)
As of 4:19:30 PM GMT+1. Market Open.

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
Name Title Pay Exercised Year Born
Dr. Michael Grosse
CEO & Chairman of the Executive Board 1.15M -- 1967
Dr. Florian Funck Dipl.Kfm.
CFO & Member of Executive Board 1.42M -- 1971
Dr. Rene Faber
Head of Bioprocess Solutions Division & Member of Executive Board 1.48M -- 1975
Dr. Alexandra Gatzemeyer
Head of the Lab Products & Services Division and Member of Executive Board 1.19M -- 1979
Ms. Patricia Spannagel
Head of Quality Assurance - Mechatronics Division Goettingen -- -- --
Ralf Mohrschladt
Physicist & Head of Supply Chain Management - Germany -- -- --
Ms. Petra Muller
Head of Investor Relations -- -- --
Mr. Maurice Phelan
President of Sartorius North America -- -- --
Dr. Theo Thijssen
President of Environmental Technology Division -- -- --

Sartorius Aktiengesellschaft

Otto-Brenner-Strasse 20
Göttingen, 37079
Germany
49 551 308 0 https://www.sartorius.com
Sector: 
Healthcare
Full Time Employees: 
14,273

Description

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Corporate Governance

Sartorius Aktiengesellschaft’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 22, 2026 at 3:30 PM UTC

Sartorius Aktiengesellschaft Earnings Date

Recent Events

March 27, 2026 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: